ALKBH5 was found aberrantly overexpressed in AML, and exerted tumor-promoting effects through post-transcriptional regulation of crucial targets such as the prognosis-associated oncogene TACC3, to promote tumorigenesis and self-renewal of cancer stem cell [113]. Here, ALKBH5 is linked to cancer.